<DOC>
	<DOCNO>NCT02515994</DOCNO>
	<brief_summary>Randomized , double-masked , control , 2-arm parallel group , multi-site , 3-month dispensing study Johnson &amp; Johnson Vision Care , Inc. ( JJVCI ) Investigational contact lens , compare market , monthly replacement contact lens . Subjects wear JJVCI investigational contact lenses daily wear basis .</brief_summary>
	<brief_title>Evaluation Johnson &amp; Johnson Vision Care Investigational Contact Lens Compared Marketed Monthly Replacement Contact Lens</brief_title>
	<detailed_description>Objective study demonstrate safety efficacy JJVCI investigational contact lens comparison market , monthly replacement contact lens , worn thirty day daily wear modality .</detailed_description>
	<mesh_term>Refractive Errors</mesh_term>
	<criteria>The subject must read , understand , sign STATEMENT OF INFORMED CONSENT receive fully execute copy form . The subject must appear able willing adhere instruction set forth clinical protocol . The subject must least 18 year age . The subject 's vertex correct spherical equivalent distance refraction must range 1.00 6.00 eye . The subject 's refractive cylinder must ≤ 1.00 Diopters eye . The subject must best correct visual acuity 20/25 good eye . Subjects wearable pair spectacle . The subject must adapt frequent replacement daily wear spherical silicone hydrogel soft contact lens wearer eye . The subject must normal eye ( i.e. , ocular medication infection type ) . Subjects must able willing wear study lenses least 6 hour day , minimum 4 day per week Currently pregnant lactate ( subject become pregnant study discontinue ) . Any systemic disease , autoimmune disease , use medication , may interfere contact lens wear . This may include , limited , diabetes , hyperthyroidism , recurrent herpes simplex/zoster , Sjögren 's syndrome , xerophthalmia , acne rosacea , StevensJohnson syndrome , immunosuppressive disease infectious disease ( e.g . hepatitis , tuberculosis ) . Use following medication within 1 week prior enrollment : oral retinoid isotretinoin ( e.g . Accutane ) , oral tetracycline , topical scopolamine , oral ( e.g . Seldane , ChlorTrimeton , Benadryl ) ophthalmic antihistamine , oral phenothiazine ( e.g. , Haldol , Mellaril , Thorazine , Elavil , Pamelor , Compazine ) , oral ophthalmic Betaadrenergic blocker ( e.g. , Propranolol , Timolol , Practolol ) , systemic steroid , prescribe counter ( OTC ) ocular medication . Entropion , ectropion , extrusion , chalazia , recurrent stye , glaucoma , history recurrent corneal erosion , aphakia , moderate corneal distortion keratometry . Any previous , plan , ocular interocular surgery ( e.g. , radial keratotomy , photorefractive keratectomy ( PRK ) , laser situ keratomileusis ( LASIK ) , etc. ) . Any grade 2 great slit lamp finding ( e.g. , edema , corneal neovascularization , corneal staining , tarsal abnormality , conjunctival injection ) FDA classification scale , previous history sign contact lensrelated corneal inflammatory event ( e.g. , past peripheral ulcer round peripheral scar ) , ocular abnormality may contraindicate contact lens wear . Any known hypersensitivity allergic reaction Optifree®Puremoist® multipurpose care solution EyeCept® rewetting drop solution Any ocular infection , allergy clinically significant ocular disease ( e.g . corneal edema , uveitis , severe keratoconjunctivitis sicca , ocular hypertension ) , ocular condition ( e.g . strabismus ) , might interfere study . Any corneal distortion result previous hard rigid gas permeable contact lens wear . Daily disposable , extend wear , monovision multifocal contact lens correction . Participation contact lens lens care product clinical trial within 30 day prior study enrollment . History binocular vision abnormality strabismus . Employee relative employee sponsor investigational clinic ( e.g. , Investigator , Coordinator , Technician )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>